Items tagged with Vaccines
TB vaccine passes safety test (post)
The vaccine candidate VPM1002 shows its safety in a study with HIV- and non-HIV-exposed newborns.
Immune boosting benefits of TB vaccine seen in infants more than a year after vaccination (post)
The immune boosting benefits of a tuberculosis vaccine can be seen in infants more than one year after vaccination, according to a new study.
BCG vaccine prevents TB in young children, but not adults (post)
Amidst longstanding debate on the effectiveness of the tuberculosis vaccine, a new study suggests that the vaccine is protective against TB in children under 5, but adolescents and adults in high-burden countries may need additional protection to maintain immunity beyond childhood.
Multiple shots of BCG vaccine protect patients with type 1 diabetes from COVID-19 (post)
BOSTON, 15 August 2022 – Researchers at Massachusetts General Hospital (MGH), published a new paper in Cell Reports Medicine demonstrating the protective potential of multiple doses of the Bacillus Calmette-Guerin (BCG) vaccine against COVID-19 and other infectious diseases.
WHO public consultation on evidence framework for new TB vaccines (post)
The Department of Immunization, Vaccines and Biologicals (IVB) at the World Health Organization (WHO) released a draft document for public consultation 'WHO Evidence Considerations for Vaccine Policy Development (ECVP) for Tuberculosis vaccines intended for Adults and Adolescents'.
The NIH/DAIDS Cross-Network (ACTG/HVTN/IMPAACT) TB Vaccine Working Group calls for people living with HIV to be included in TB vaccine development (post)
SEATTLE (Friday, October 14, 2022) – People living with HIV must be included in clinical trials for new tuberculosis vaccine candidates currently in the development pipeline, say experts on an international panel convened last year to address gaps in the current TB vaccine landscape.
Diversifying the next generation of TB vaccines (post)
SAN ANTONIO (October 17, 2022) – Mirroring the all-hands-on-deck collaborative approach that accelerated the development of a variety of COVID-19 vaccines during the pandemic, the National Institutes of Health is seeking to spark similar innovation for a longstanding, intractable disease: tuberculosis. As part of this national push, NIH’s National Institute of Allergy and Infectious Diseases awarded Texas Biomedical Research Institute (Texas Biomed) and The Access to Advanced Health Institute (AAHI) in Seattle, Washington, a $3.5 million, five-year Innovation for Tuberculosis Vaccine Discovery grant.
Researchers discover gut mechanism that triggers innate immunity against respiratory infections (post)
Scientists studying how a common tuberculosis vaccine works have discovered that it induces a previously unknown mechanism in the gut that triggers a systemic immune alert, which then causes changes in the innate immune system in the lung to fend off not just tuberculosis, but a broad range of respiratory pathogens.
Kicking goals against TB (post)
A potential new tuberculosis (TB) vaccine developed at James Cook University is one of six now being tested in the first phase of a US $1.7 million head-to-head vaccine tournament, funded by the Bill and Melinda Gates Foundation.
TB vaccine advocacy fellowship 2023 - APPLY NOW (post)
The TB Vaccine Advocacy Roadmap (TB Vax ARM) and the Stop TB Partnership Working Group on New TB Vaccines announced a new advocacy fellowship program, set to take place in February 2023 in the run up to World TB Day. The program will convene six fellows representing TB affected communities, advocates, and early career researchers from high TB burden countries for an online skill building and co-learning program. The goal of the program is to help cultivate a new generation of TB vaccine R&D advocates and stimulate more diverse advocacy efforts for TB vaccine R&D ahead of the UN High-Level Meeting on TB in September 2023 and beyond.
Page 21 of 30 · Total posts: 0
←First 20 21 22 Last→